夫妻在线免费观看黄色一级大片 ,欧美一二三区在线播放,亚洲5555视频在线观看

Having the qualifications for the production and operation of controlled drugs and holding over 60 ANDA approvals; Having a mature sales network in the US market; A CMO site recognized by multinational pharmaceutical companies for a long time.

The company's important strategic layout for promoting internationalization includes cutting-edge information research, new drug discovery and exploration, high-end formulation research and industrialization, and coordinated development with the international registration, production, export, and independent marketing of the company's products. Focusing on strategic areas such as anesthesia, analgesia, and central nervous system diseases, there are products under research in innovative drugs, high-end sustained-release formulations, and complex injection formulations.

PuraCap Pharmaceuticals LLC, established in 2008 in New Jersey, is among the earliest Chineses-backed pharmaceutical companies in the USA. The company is engaged in the market entry and distribution of OTC products in the US, and its specialty products are soft gel capsules.

Commercial pharmaceutical company covering eight French speaking regions in West Africa

The first modern pharmaceutical factory in West Africa, ending the history of Mali being unable to produce drugs; Production of injectable, oral solid/liquid and other preparations

Modern pharmaceutical factories in Ethiopia; the first pharmaceutical factory invested in and constructed by a Hubei enterprise in Ethiopia; production of oral solid/liquid formulations and small volume injections.

The first oral solid dosage form factory in Hubei Province to be certified by the US FDA and the UK MHRA; Focus on the research and development, registration, production, and international sales of sustained-release oral solid preparations and transdermal generic drugs that meet national standards.

The first soft capsule production enterprise in Hubei Province to pass the US FDA certification; Leading supplier of soft capsule drug formulations in the US market; A leading enterprise in the research and production of global soft capsule drug formulations.

Having dual qualifications from NMPA and FDA, covering injections and high-end oral solid preparations, we undertake the entire process of clinical sample to commercial production commissioning business.

Headquartered in Aachen of Germany, the company focuses on the R&D and commercialization of innovative pharmaceutical products for anesthesia and critical care.

The company established a subsidiary in the Republic of Uzbekistan in 2016, and established a professional marketing academic promotion team and registration team. The company has registered six kinds of Uyghur medicines, and the sales scope covers the entire territory of Uzbekistan.